(Q23909540)

2

0 references

Y.-L. Tain

3

0 references

K. Engels

4

0 references

C. Baylis

American Journal of Physiology - Renal Physiology

5

0 references

language of work or name

English

0 references

publication date

8 August 2006

0 references

published in

0 references

volume

292

0 references

issue

1

0 references

page(s)

F192-F196

0 references

on focus list of Wikimedia project

Wikimedia–NIOSH collaboration

0 references

2 references

2 February 2024

inferred from email address

cites work

Upregulation of arterial serotonin 1B and 2B receptors in deoxycorticosterone acetate-salt hypertension

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Resistance to renal damage by chronic nitric oxide synthase inhibition in the Wistar-Furth rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Ischemic preconditioning-mediated restoration of membrane dystrophin during reperfusion correlates with protection against contraction-induced myocardial injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Sexual dimorphism in the aging kidney: Effects on injury and nitric oxide system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Protection of Wistar Furth Rats from Chronic Renal Disease Is Associated with Maintained Renal Nitric Oxide Synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Role of endothelium-derived nitric oxide in hemodynamic adaptations after graded renal mass reduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

L-arginine as a therapeutic tool in kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Skeletal muscle contractions stimulate cGMP formation and attenuate vascular smooth muscle myosin phosphorylation via nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Total nitric oxide production is low in patients with chronic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Indices of activity of the nitric oxide system in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Role of nitric oxide in the renal hemodynamic response to unilateral nephrectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Acute changes in urinary excretion of nitrite + nitrate do not necessarily predict renal vascular NO production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Renal neuronal nitric oxide synthase protein expression as a marker of renal injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Reduced nitric oxide synthase activity in rats with chronic renal disease due to glomerulonephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Uremic levels of BUN do not cause nitric oxide deficiency in rats with normal renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Chronic nitric oxide inhibition model six years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Renal and systemic nitric oxide synthesis in rats with renal mass reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Nitric Oxide Production Is Reduced in Patients With Chronic Renal Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021

Measurement of nitrite and nitrate levels in plasma and urine--what does this measure tell us about the activity of the endogenous nitric oxide system?

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021

Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021

Hypertensive response to chronic NO synthase inhibition is different in Sprague-Dawley rats from two suppliers

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021

Nitric oxide production is low in end-stage renal disease patients on peritoneal dialysis.

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021

Low nitric oxide production in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00146.2006

7 January 2021